RepliCel Life Sciences Inc.

The current price of REPCF is 0.0428 USD — it has increased by 4.99% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange RepliCel Life Sciences Inc. stocks are traded under the ticker REPCF.

RepliCel Life Sciences Inc. is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.

REPCF stock is 4.75% volatile and has beta coefficient of 0.00. Check out the list of the most volatile stocks — is RepliCel Life Sciences Inc. there?

Yes, you can track RepliCel Life Sciences Inc. financials in yearly and quarterly reports right on TradingView.

Today RepliCel Life Sciences Inc. has the market capitalization of ‪2.61 M‬, it has decreased by 13.09% over the last week.

No, REPCF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, REPCF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RepliCel Life Sciences Inc. stock right from TradingView charts — choose your broker and connect to your account.

REPCF reached its all-time high on Aug 3, 2004 with the price of 339.0000 USD, and its all-time low was 0.0257 USD and was reached on Dec 5, 2023.
See other stocks reaching their highest and lowest prices.

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RepliCel Life Sciences Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RepliCel Life Sciences Inc. stock shows the sell signal. See more of RepliCel Life Sciences Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RepliCel Life Sciences Inc. EBITDA is ‪−1.01 M‬ USD, and current EBITDA margin is −394.27%. See more stats in RepliCel Life Sciences Inc. financial statements.